Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D

βA4-Amyloid peptide, the main component of the amyloid plaques in the brain of Alzheimer's disease patients is produced from amyloid precursor protein (APP) by proteolytical processing. Several lines of evidence suggest a direct role for cathepsin D, the major endosomal/lysosomal aspartic endop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 1996-11, Vol.271 (44), p.27241-27244
Hauptverfasser: Saftig, Paul, Peters, Christoph, von Figura, Kurt, Craessaerts, Katleen, Van Leuven, Fred, De Strooper, Bart
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27244
container_issue 44
container_start_page 27241
container_title The Journal of biological chemistry
container_volume 271
creator Saftig, Paul
Peters, Christoph
von Figura, Kurt
Craessaerts, Katleen
Van Leuven, Fred
De Strooper, Bart
description βA4-Amyloid peptide, the main component of the amyloid plaques in the brain of Alzheimer's disease patients is produced from amyloid precursor protein (APP) by proteolytical processing. Several lines of evidence suggest a direct role for cathepsin D, the major endosomal/lysosomal aspartic endopeptidase, in βA4-amyloid peptide generation. Here we tested this hypothesis using primary cultures of hippocampal neurons derived from cathepsin D-deficient (knock out) mice and expressing wild-type human APP and two clinical APP variants via recombinant Semliki Forest virus. We demonstrate APP secretory processing, production of carboxyl-terminal amyloid fragments, and secretion of the βA4-amyloid peptide in the complete absence of cathepsin D. The results rule out cathepsin D as a critical component of α-, β-, or γ-secretase and therefore as a primary target for drugs aimed at decreasing the βA4-amyloid peptide burden in Alzheimer's disease.
doi_str_mv 10.1074/jbc.271.44.27241
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78514283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925818352244</els_id><sourcerecordid>15779722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-f37ff8b15490736ccd7eb61326284af0581727c30ed0f04805aa0b0e6e69de113</originalsourceid><addsrcrecordid>eNqFkcGL1DAUxoMo67h69yL0IHvr-F6aNqm3ZVYdYVEPCt5Cmr5Os7RNTdqV_e_NOIMHQQyBd_h-38fjfYy9RNgiSPHmrrFbLnErRBpc4CO2QVBFXpT4_THbAHDMa16qp-xZjHeQnqjxgl2oGoHX1Yb11-PD4F3rDzQ5m30J3lKMbjpkvsv262im7Ewkjewaog9HaiE3Zenv3Tx7a8bZDNknWoOfYnZD90c-BezM0tOc4rKb5-xJZ4ZIL87zkn17_-7rbp_ffv7wcXd9m1sh5JJ3hew61WApapBFZW0rqamw4BVXwnRQKpRc2gKohQ6EgtIYaIAqquqWEItLdnXKnYP_sVJc9OiipWEwE_k1aqlKFFwV_wWxlLKWnCcQTqANPsZAnZ6DG0140Aj62IJOLejUghZC_24hWV6ds9dmpPaP4Xz2pL8-6b079D9dIN04b3sa_455e8IoHezeUdDROpostcliF9169-8dfgF8paJb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15779722</pqid></control><display><type>article</type><title>Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Saftig, Paul ; Peters, Christoph ; von Figura, Kurt ; Craessaerts, Katleen ; Van Leuven, Fred ; De Strooper, Bart</creator><creatorcontrib>Saftig, Paul ; Peters, Christoph ; von Figura, Kurt ; Craessaerts, Katleen ; Van Leuven, Fred ; De Strooper, Bart</creatorcontrib><description>βA4-Amyloid peptide, the main component of the amyloid plaques in the brain of Alzheimer's disease patients is produced from amyloid precursor protein (APP) by proteolytical processing. Several lines of evidence suggest a direct role for cathepsin D, the major endosomal/lysosomal aspartic endopeptidase, in βA4-amyloid peptide generation. Here we tested this hypothesis using primary cultures of hippocampal neurons derived from cathepsin D-deficient (knock out) mice and expressing wild-type human APP and two clinical APP variants via recombinant Semliki Forest virus. We demonstrate APP secretory processing, production of carboxyl-terminal amyloid fragments, and secretion of the βA4-amyloid peptide in the complete absence of cathepsin D. The results rule out cathepsin D as a critical component of α-, β-, or γ-secretase and therefore as a primary target for drugs aimed at decreasing the βA4-amyloid peptide burden in Alzheimer's disease.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.271.44.27241</identifier><identifier>PMID: 8910296</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Amyloid beta-Peptides - biosynthesis ; Amyloid beta-Peptides - chemistry ; Amyloid beta-Protein Precursor - biosynthesis ; Amyloid beta-Protein Precursor - chemistry ; Amyloid beta-Protein Precursor - metabolism ; Animals ; Base Sequence ; Cathepsin D - deficiency ; Cells, Cultured ; Crosses, Genetic ; DNA Primers ; Genetic Variation ; Heterozygote ; Hippocampus - metabolism ; Humans ; Mice ; Mice, Knockout ; Molecular Sequence Data ; Neurons - metabolism ; Polymerase Chain Reaction ; Protein Processing, Post-Translational ; Semliki forest virus ; Transfection</subject><ispartof>The Journal of biological chemistry, 1996-11, Vol.271 (44), p.27241-27244</ispartof><rights>1996 © 1996 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-f37ff8b15490736ccd7eb61326284af0581727c30ed0f04805aa0b0e6e69de113</citedby><cites>FETCH-LOGICAL-c447t-f37ff8b15490736ccd7eb61326284af0581727c30ed0f04805aa0b0e6e69de113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8910296$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saftig, Paul</creatorcontrib><creatorcontrib>Peters, Christoph</creatorcontrib><creatorcontrib>von Figura, Kurt</creatorcontrib><creatorcontrib>Craessaerts, Katleen</creatorcontrib><creatorcontrib>Van Leuven, Fred</creatorcontrib><creatorcontrib>De Strooper, Bart</creatorcontrib><title>Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>βA4-Amyloid peptide, the main component of the amyloid plaques in the brain of Alzheimer's disease patients is produced from amyloid precursor protein (APP) by proteolytical processing. Several lines of evidence suggest a direct role for cathepsin D, the major endosomal/lysosomal aspartic endopeptidase, in βA4-amyloid peptide generation. Here we tested this hypothesis using primary cultures of hippocampal neurons derived from cathepsin D-deficient (knock out) mice and expressing wild-type human APP and two clinical APP variants via recombinant Semliki Forest virus. We demonstrate APP secretory processing, production of carboxyl-terminal amyloid fragments, and secretion of the βA4-amyloid peptide in the complete absence of cathepsin D. The results rule out cathepsin D as a critical component of α-, β-, or γ-secretase and therefore as a primary target for drugs aimed at decreasing the βA4-amyloid peptide burden in Alzheimer's disease.</description><subject>Amino Acid Sequence</subject><subject>Amyloid beta-Peptides - biosynthesis</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>Amyloid beta-Protein Precursor - biosynthesis</subject><subject>Amyloid beta-Protein Precursor - chemistry</subject><subject>Amyloid beta-Protein Precursor - metabolism</subject><subject>Animals</subject><subject>Base Sequence</subject><subject>Cathepsin D - deficiency</subject><subject>Cells, Cultured</subject><subject>Crosses, Genetic</subject><subject>DNA Primers</subject><subject>Genetic Variation</subject><subject>Heterozygote</subject><subject>Hippocampus - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Molecular Sequence Data</subject><subject>Neurons - metabolism</subject><subject>Polymerase Chain Reaction</subject><subject>Protein Processing, Post-Translational</subject><subject>Semliki forest virus</subject><subject>Transfection</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcGL1DAUxoMo67h69yL0IHvr-F6aNqm3ZVYdYVEPCt5Cmr5Os7RNTdqV_e_NOIMHQQyBd_h-38fjfYy9RNgiSPHmrrFbLnErRBpc4CO2QVBFXpT4_THbAHDMa16qp-xZjHeQnqjxgl2oGoHX1Yb11-PD4F3rDzQ5m30J3lKMbjpkvsv262im7Ewkjewaog9HaiE3Zenv3Tx7a8bZDNknWoOfYnZD90c-BezM0tOc4rKb5-xJZ4ZIL87zkn17_-7rbp_ffv7wcXd9m1sh5JJ3hew61WApapBFZW0rqamw4BVXwnRQKpRc2gKohQ6EgtIYaIAqquqWEItLdnXKnYP_sVJc9OiipWEwE_k1aqlKFFwV_wWxlLKWnCcQTqANPsZAnZ6DG0140Aj62IJOLejUghZC_24hWV6ds9dmpPaP4Xz2pL8-6b079D9dIN04b3sa_455e8IoHezeUdDROpostcliF9169-8dfgF8paJb</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>Saftig, Paul</creator><creator>Peters, Christoph</creator><creator>von Figura, Kurt</creator><creator>Craessaerts, Katleen</creator><creator>Van Leuven, Fred</creator><creator>De Strooper, Bart</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19961101</creationdate><title>Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D</title><author>Saftig, Paul ; Peters, Christoph ; von Figura, Kurt ; Craessaerts, Katleen ; Van Leuven, Fred ; De Strooper, Bart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-f37ff8b15490736ccd7eb61326284af0581727c30ed0f04805aa0b0e6e69de113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Amino Acid Sequence</topic><topic>Amyloid beta-Peptides - biosynthesis</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>Amyloid beta-Protein Precursor - biosynthesis</topic><topic>Amyloid beta-Protein Precursor - chemistry</topic><topic>Amyloid beta-Protein Precursor - metabolism</topic><topic>Animals</topic><topic>Base Sequence</topic><topic>Cathepsin D - deficiency</topic><topic>Cells, Cultured</topic><topic>Crosses, Genetic</topic><topic>DNA Primers</topic><topic>Genetic Variation</topic><topic>Heterozygote</topic><topic>Hippocampus - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Molecular Sequence Data</topic><topic>Neurons - metabolism</topic><topic>Polymerase Chain Reaction</topic><topic>Protein Processing, Post-Translational</topic><topic>Semliki forest virus</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saftig, Paul</creatorcontrib><creatorcontrib>Peters, Christoph</creatorcontrib><creatorcontrib>von Figura, Kurt</creatorcontrib><creatorcontrib>Craessaerts, Katleen</creatorcontrib><creatorcontrib>Van Leuven, Fred</creatorcontrib><creatorcontrib>De Strooper, Bart</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saftig, Paul</au><au>Peters, Christoph</au><au>von Figura, Kurt</au><au>Craessaerts, Katleen</au><au>Van Leuven, Fred</au><au>De Strooper, Bart</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>271</volume><issue>44</issue><spage>27241</spage><epage>27244</epage><pages>27241-27244</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>βA4-Amyloid peptide, the main component of the amyloid plaques in the brain of Alzheimer's disease patients is produced from amyloid precursor protein (APP) by proteolytical processing. Several lines of evidence suggest a direct role for cathepsin D, the major endosomal/lysosomal aspartic endopeptidase, in βA4-amyloid peptide generation. Here we tested this hypothesis using primary cultures of hippocampal neurons derived from cathepsin D-deficient (knock out) mice and expressing wild-type human APP and two clinical APP variants via recombinant Semliki Forest virus. We demonstrate APP secretory processing, production of carboxyl-terminal amyloid fragments, and secretion of the βA4-amyloid peptide in the complete absence of cathepsin D. The results rule out cathepsin D as a critical component of α-, β-, or γ-secretase and therefore as a primary target for drugs aimed at decreasing the βA4-amyloid peptide burden in Alzheimer's disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>8910296</pmid><doi>10.1074/jbc.271.44.27241</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1996-11, Vol.271 (44), p.27241-27244
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_78514283
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Amino Acid Sequence
Amyloid beta-Peptides - biosynthesis
Amyloid beta-Peptides - chemistry
Amyloid beta-Protein Precursor - biosynthesis
Amyloid beta-Protein Precursor - chemistry
Amyloid beta-Protein Precursor - metabolism
Animals
Base Sequence
Cathepsin D - deficiency
Cells, Cultured
Crosses, Genetic
DNA Primers
Genetic Variation
Heterozygote
Hippocampus - metabolism
Humans
Mice
Mice, Knockout
Molecular Sequence Data
Neurons - metabolism
Polymerase Chain Reaction
Protein Processing, Post-Translational
Semliki forest virus
Transfection
title Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A29%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloidogenic%20Processing%20of%20Human%20Amyloid%20Precursor%20Protein%20in%20Hippocampal%20Neurons%20Devoid%20of%20Cathepsin%20D&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Saftig,%20Paul&rft.date=1996-11-01&rft.volume=271&rft.issue=44&rft.spage=27241&rft.epage=27244&rft.pages=27241-27244&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.271.44.27241&rft_dat=%3Cproquest_cross%3E15779722%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15779722&rft_id=info:pmid/8910296&rft_els_id=S0021925818352244&rfr_iscdi=true